McCourt Timothy Francis 4
Research Summary
AI-generated summary
CME (CME) Sr MD Timothy McCourt Receives Stock Award
What Happened
Timothy F. McCourt, Senior Managing Director & Global Head, Equity & FX at CME Group, had 5,504 performance/restricted shares vest on March 15, 2026 (code A), valued at $1,713,946 (price $311.40). To cover tax withholding (code F), he surrendered 2,810 shares ( $875,034) and an additional 94 shares ($29,272) back to the company. Net result: McCourt retained 2,600 shares from the vesting, a net increase worth approximately $809,640.
Key Details
- Transaction date: 2026-03-15; filing date: 2026-03-17 (filed on time).
- Award: 5,504 shares @ $311.40 = $1,713,946 (code A).
- Tax withholding: 2,810 shares @ $311.40 = $875,034 (code F); 94 shares @ $311.40 = $29,272 (code F).
- Net shares retained from this vesting: 2,600 shares (5,504 − 2,904) worth ~ $809,640.
- Footnotes: Vesting represents performance shares granted in 2022 under CME’s Omnibus Stock Plan and was determined by total shareholder return vs. the S&P 500 for 1/1/2023–12/31/2025 (F1). Shares were surrendered to satisfy tax withholding on the performance share award (F2) and on restricted stock vesting (F3).
- Filing timeliness: Report covers 3/15/2026 transactions and was filed 3/17/2026 (within the usual two-business-day window).
Context
- This was a compensation-related vesting (an award), not an open-market sale or purchase; the surrendered shares were used solely to meet tax withholding obligations and do not necessarily indicate trading intent.
- For retail investors: awards reflect standard executive compensation practices and are less informative about an insider’s view of the stock than outright purchases.